BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 30763568)

  • 1. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Haukedal H; Freude K
    J Mol Biol; 2019 Apr; 431(9):1818-1829. PubMed ID: 30763568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.
    Lall D; Baloh RH
    J Clin Invest; 2017 Sep; 127(9):3250-3258. PubMed ID: 28737506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic architecture of amyotrophic lateral sclerosis and frontotemporal dementia : Overlap and differences].
    Synofzik M; Otto M; Ludolph A; Weishaupt JH
    Nervenarzt; 2017 Jul; 88(7):728-735. PubMed ID: 28573364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation in ALS/FTD pathogenesis.
    McCauley ME; Baloh RH
    Acta Neuropathol; 2019 May; 137(5):715-730. PubMed ID: 30465257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
    Gascon E; Gao FB
    J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
    EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial Cell Dysfunction in
    Ghasemi M; Keyhanian K; Douthwright C
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy in Amyotrophic Lateral Sclerosis.
    Fang T; Je G; Pacut P; Keyhanian K; Gao J; Ghasemi M
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
    Ji AL; Zhang X; Chen WW; Huang WJ
    J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Mutations in SOD1 and C9orf72 Genes on Autophagy in Lymphomonocytes in Myotrophic Lateral Sclerosis.
    Kochergin IA; Shpilyukova YA; Lysogorskaia EV; Abramycheva NY; Zakharova MN; Illarioshkin SN
    Bull Exp Biol Med; 2019 Sep; 167(5):667-670. PubMed ID: 31625064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
    García-García R; Martín-Herrero L; Blanca-Pariente L; Pérez-Cabello J; Roodveldt C
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia.
    Radford RA; Morsch M; Rayner SL; Cole NJ; Pountney DL; Chung RS
    Front Cell Neurosci; 2015; 9():414. PubMed ID: 26578880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Little Helpers or Mean Rogue-Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis.
    Cihankaya H; Theiss C; Matschke V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
    Fecto F; Siddique T
    J Mol Neurosci; 2011 Nov; 45(3):663-75. PubMed ID: 21901496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.